Found 35 matching trials
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies PHASE1 The purpose of this study is to determine the safety, tolerability; and to ...
Show More Status
Active Not Recruiting
Location
UCLA Hematologyoncology
Learn More & Join Trial
A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma PHASE2 This study is a multi-center, open-label, single-arm, non-randomized phase ...
Show More Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Learn More & Join Trial
A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma PHASE1 This phase I clinical study was to investigate the safety, tolerability, an...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma PHASE2 The goal of this phase II randomized open label study is to compare the rat...
Show More Location
H. General Univ. de Alicante
Learn More & Join Trial
Zanubritnib and Anti-MAG Neuropathy PHASE2 The MAZINGA study is a multicenter, open-label, single-arm Phase IIA clinic...
Show More Location
CTU Ematologia, Grande Ospedale Metropolitano Niguarda
Learn More & Join Trial
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL PHASE3 To compare efficacy between zanubrutinib versus bendamustine and rituximab ...
Show More Status
Active Not Recruiting
Location
Augusta University
Learn More & Join Trial
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma PHASE1 The purpose of this study is to is to determine the effects (good and bad) ...
Show More Location
University of Miami
Learn More & Join Trial
Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants PHASE2 The primary objective of this study was to evaluate if the addition of zanu...
Show More Location
St Jude Medical Center
Learn More & Join Trial
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma PHASE3 The purpose of the study is to compare the efficacy of zanubrutinib plus ob...
Show More Status
Active Not Recruiting
Location
Ucsf Fresno University of California San Francisco Fresno
Learn More & Join Trial
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients PHASE3 The goal of this clinical trial is to compare the efficacy and tolerability...
Show More Status
Active Not Recruiting
Location
Medical University of Vienna
Learn More & Join Trial